Genetic Signatures launches prospectus for IPO
19 November, 2014 by Dylan Bushell-EmblingGenetic Signatures has launched a prospectus for an IPO on the ASX to help support the molecular diagnostics company's growth ambitions.
Measuring the true reach of research
13 November, 2014A new, freely available tool helps researchers more comprehensively track the impact of their research.
ARC 2015 major grants announced
06 November, 2014The 2015 Australian Research Council (ARC) Major Grants have been announced with $354 million distributed to 941 new research projects.
Koala transcriptome revealed
21 October, 2014 by Susan WilliamsonA blueprint for the koala genome has been sequenced, with researchers transcribing 15,000 koala genes.
Whole human genome sequencing partnership
09 October, 2014The Australian Genome Research Facility and the Garvan Institute of Medical Research have announced a collaboration that will help facilitate Australia's access to whole human genome sequencing.
DNA, RNA and protein extraction from skin tissue
09 October, 2014 by MP Biomedicals Australasia P/LEffective, efficient sample preparation is critical to successful downstream results. Now an effective method exists for the extraction of intact, biologically functional macromolecules from skin.
Automated purification of high-quality genomic DNA
09 October, 2014 by Eppendorf South Pacific Pty LtdThe Eppendorf epMotion M5073 with MagSep Tissue gDNA kit is an efficient and effective way of isolating genomic DNA in an automated environment.
Genera teams up with Beckman Coulter, taps new CEO
03 October, 2014 by Dylan Bushell-EmblingGenera Biosystems has announced a business collaboration with Beckman Coulter Lifesciences for molecular diagnostics assays and promoted director Richard Hannebery to the post of CEO.
Genetic Technologies launches BrevaGenplus
02 October, 2014 by Dylan Bushell-EmblingGenetic Technologies has launched the enhanced version of its breast cancer risk test and appointed two new non-executive directors to help with its restructuring.
GTG selling Australian genetics business
23 September, 2014 by Dylan Bushell-EmblingGenetic Technologies (ASX:GTG) will sell its Australian genetics testing business to a Primary Health Care subsidiary for $2m.
GTG restructures to focus on molecular diagnosis
16 September, 2014 by Dylan Bushell-EmblingGenetic Technologies (ASX:GTG) has announced a restructuring project, as well as plans to launch the upgraded version of breast cancer risk test BREVAGen next month.
MicroRNA profiling
15 September, 2014 by Merck Pty LimitedAs microRNA (miRNA)-based research shifts from discovery of new miRNAs to elucidating their biological roles and their utility as biomarkers, robust methods are needed to profile large sample cohorts.
Coffee genome sequenced
09 September, 2014An international research effort into the genome sequencing of the coffee plant has revealed its 'convergent evolution' with unrelated cacao and tea plants.
Federal court upholds decision on Myriad patent
05 September, 2014The Federal Court of Australia has upheld its decision from last year in favour of Myriad Genetics patenting isolated DNA associated with breast cancer gene mutations.
Telomeres tell on cancer cells
26 August, 2014Different DNA sequences in the telomeres of cancer cells may help unravel how these cells maintain their ability to endlessly multiply.
